Distal Cholangiocarcinoma

• CLINICAL_TRIALS research · 2026-01-21
  Clinical Trial Update: Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy [NA]

  A clinical trial evaluating outcomes after laparoscopic versus open pancreaticoduodenectomy for pancreatic and periampullary cancers is curr…

• CLINICAL_TRIALS research · 2025-12-01
  Clinical Trial Update: Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma [Phase 2]

  Phase 2 clinical trial evaluating durvalumab in combination with intraductal radiofrequency ablation for unresectable extrahepatic cholangio…

• CLINICAL_TRIALS research · 2025-09-30
  Clinical Trial Update: ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer [NA]

  The ToPanc trial is evaluating survival after total versus partial pancreaticoduodenectomy for pancreatic head adenocarcinoma, distal cholan…

• CLINICAL_TRIALS research · 2025-04-11
  Clinical Trial Update: Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma [Phase 2, Phase 3]

  A Phase 2/3 clinical trial compares neoadjuvant gemcitabine and cisplatin with perioperative pembrolizumab versus upfront surgery in patient…

• CLINICAL_TRIALS research · 2024-12-05
  Clinical Trial Update: Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer [Phase 2]

  Phase 2 trial evaluating toripalimab in combination with capecitabine as postoperative adjuvant therapy for resectable extrahepatic biliary …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.